Q/C Technologies, Inc. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three
Q/C Technologies, Inc. (QCLS) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three of $129.88 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $129.88K.
- 2022-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $5.81K.
- 2022-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $51.35K.
- 2021-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $2.12K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three |
|---|---|
| 2026-06-30 | $129.88K 10-Q · filed 2026-08-12 |
| 2022-06-30 | $5.81K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $51.35K 10-Q · filed 2022-05-16 |
| 2021-09-30 | $2.12K 10-Q/A · filed 2021-11-15 |
| 2021-06-30 | $8.49K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |